The Pascal valve repair device boasts a pivotal hit and US approval, but can it compete?
Staffing levels changed little across 2020 as M&A slowed – but sales are another story.
Transcatheter technologies could be the future – but a distant one.
Abbott’s latest aortic valve launch is unlikely to gain it a meaningful slice of the market; meanwhile, Edwards’ attention has switched to tricuspid.
Medtronic’s quarterly results yesterday might presage a recovery, and some groups are in dire need of one.
Beset with problems from the off, the Lotus Edge aortic valve has finally been discontinued.
Welcome to the calm before the Covid-19 storm.